Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

Monoclonal antibodies are widely used to treat non-infectious conditions but are costly. Vaccines could offer a cost-effective alternative but have been limited by sub-optimal T-cell stimulation and/or weak vaccine responses in recipients, for example, in elderly patients. We have previously shown t...

Full description

Saved in:

Bibliographic Details
Published in:	npj vaccines Vol. 2; no. 1; p. 30
Main Authors:	Zeltins, Andris, West, Jonathan, Zabel, Franziska, El Turabi, Aadil, Balke, Ina, Haas, Stefanie, Maudrich, Melanie, Storni, Federico, Engeroff, Paul, Jennings, Gary T., Kotecha, Abhay, Stuart, David I, Foerster, John, Bachmann, Martin F.
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 23.10.2017 Nature Publishing Group
Subjects:	631/250/590 631/61/24/590 692/308/2778 Allergies Alzheimer's disease Antigens Biomedical and Life Sciences Biomedicine Immune system Immunoglobulins Infectious Diseases Medical Microbiology Older people Psoriasis Public Health Skin diseases Tetanus Vaccine Vaccines Virology
ISSN:	2059-0105, 2059-0105
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!